Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells

Apoptosis

Volumn 11, Issue 10, 2006, Pages 1825-1835

  Miura, Yoshie ^a   Nishimura, Yasumitsu ^a   Katsuyama, Hironobu ^a   Maeda, Megumi ^a   Hayashi, Hiroaki ^a   Dong, Maolong ^a   Hyodoh, Fuminori ^a   Tomita, Masafumi ^a   Matsuo, Yoshinobu ^b   Uesaka, Ayuko ^c   Kuribayashi, Kozo ^c   Nakano, Takashi ^c   Kishimoto, Takumi ^d   Otsuki, Takemi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Grandsoul Research Institute for Immunology   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

Apoptosis; Asbestos; Bcl 2; IL 10; T cell

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ASBESTOS; CHRYSOTILE; INTERLEUKIN 10; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; ASBESTOSIS; CD4 LYMPHOCYTE COUNT; CELL IMMORTALIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RETROVIRUS; T LYMPHOCYTE; TUMOR GROWTH;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASBESTOS; ASBESTOS, SERPENTINE; ASBESTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HUMANS; INTERLEUKIN-10; LEUKOCYTES; MESOTHELIOMA; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33748560513     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-9235-4     Document Type: Article

References (37)

1. Moosman BT, Bignon J, Corn M, Seatona A, Gee JBL (1990) Asbestos: scientific developments and implications for public policy. Science 247:294-301
2. Moosman BT, Churg A (1998) State-of-the-art: mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157:1666-1680
3. Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397-408
4. Sterman DH, Albelda SM (2005) Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology 10:266-283
5. Hughes RS (2005) Malignant pleural mesothelioma. Am J Med Sci 329:29-44
6. http://www-cie.iarc.fr/htdocs/monographs/vol68/silica.htm
7. Upadhyay D, Kamp DW (2003) Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 228:650-659
8. Shukla A, Ramos-Nino M, Mossman B (2003) Cell signaling and transcription factor activation by asbestos in lung injury and disease. Int J Biochem Cell Biol 35:1198-1209
9. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT (2003) Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 34:1117-1129
10. Kamp DW, Panduri V, Weitzman SA, Chandel N (2002) Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. Mol Cell Biochem 234-235:153-160
11. Panduri V, Weitzman SA, Chandel NS, Kamp DW (2003) The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis. Am J Respir Cell Mol Biol 28:241-248
12. Panduri V, Weitzman SA, Chandel N, Kamp DW (2004) Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 286:L1220-L11227
13. Song L, Turkson J, Karrs JG, Jove R, Haura EB (2003) Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22:4150-4165
14. Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B (2004) Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Oncogene 23:3530-3540
15. Aikoh T, Tomokuni A, Matsuki T, Hyodoh F, Ueki H, Otsuki T, Ueki A (1998) Activation-induced cell death in human peripheral bood lymphocytes after stimulation with silicatein vitro. Int J Oncol 12:1355-1359
16. Ma Z, Otsuki T, Tomokuni A, Aikoh T, Matsuki T, Sakaguchi H, Isozaki Y, Hyodoh F, Uehira K, Isoda K, Ueki A (1999) Man-made mineral fibers induce apoptosis of human peripheral blood mononuclear cells similarly to chrysotile B. Int J Mol Med 4:633-637
17. Ueki A, Yamaguchi M, Ueki H, Watanabe Y, Ohsawa G, Kinugawa K, Kawakami Y, Hyodoh F (1994) Polychlonal human T-cell activation by silicate in vitro. Immunology 82:332-335
18. Hyodoh F, Takata-Tomokuni A, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Katsuyama H, Matsuo Y, Otsuki T (2005) Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scan J Immunol 61:442-448
19. Miyoshi I, Kubonishi I, Yoshimoto S (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T cells. Nature 294:770-771
20. Otsuki T, Hata H, Harada N, Matsuzaki H, Yata K, Wada H, Yawata Y. Ueki A, Yamada O (2000) Cellular biological differences between KMS-12-PE and KMS-12-BM human myeloma cell lines, which were established from a single patient. Int J Hematol 72:216-222
21. Otsuki T, Yata K, Takata-Tomokuni A, Hyodoh F, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Tsujioka T, Sato Y, Murakami H, Sadahira Y, Sugihara T (2004) Expression of PGP9.5 (Protein Gene Product 9.5)/UCHL-1 (Ubiquitin-C-terminal hydrolase 1) in human myeloma cells. Br J Haematol 127:292-298
22. Miura Y, Murata Y, Utsumi K, Takahata K, Tada M, Otsuki T (2005) The inhibitory effect of dibutyryl cyclicAMP on docosahexaenoic acid-induced apoptosis involves phosphatidylinositol-3 kinase pathway in HL-60 cells. Environ Health Prev Med 10:184-189
23. Takata-Tomokuni A, Ueki A, Shiwa M, Isozaki Y, Hatayama T, Katsuyama H, Hyodoh F, Fujimoto W, Ueki H, Kusaka M, Arikuni H, Otsuki T (2005) Detection, epitope-mapping, and function of anti-Fas autoantibody in patients with silicosis. Immunology 116:221-229
24. Otsuki T, Yamada O, Kurebayashi J, Moriya T, Sakaguchi H, Kunisue H, Yata K, Uno M, Yawata Y, Ueki A (2000) Estrogen receptors in human myeloma cells. Cancer Res 60:1434-1441
25. Otsuki T, Yata K, Sakaguchi H, Kurebayashi J, Matsuo Y, Uno M, Fujii T, Eda S, Isozaki Y, Yawata Y, Yamada O,Wada H, Sugihara T, Ueki A (2002) IL-10 abolishes the growth inhibitory effects of all trans retinoic acid (ATRA) on human myeloma cells. Br J Haematol 116:787-795
26. Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381-392
27. Steinman RA, Wentzel A, Lu Y, Stehle C, Grandis JR (2003) Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene 22:3608-3615
28. Gao H, Guo RF, Speyer CL, Reuben J, Neff TA, Hoesel LM, Riedemann NC, McClintock SD, Sarma JV, Van Rooijen N, Zetoune FS, Ward PA (2004) Stat3 activation in acute lung injury. J Immunol 172:7703-7712
29. Alas S, Bonavida B (2001) Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 61:5137-5144
30. Alas S, Emmanouilides C, Bonavida B (2001) Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin. Cancer Res 7:709-723
31. Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, Ueki H, Kusaka M, Kishimoto T, Ueki A (1997) Elevation soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumors. Clin Exp Immunol 110:303-309
32. Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, Kusaka M, Ueki H, Kita S, Ueki A (1998) Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 94:258-262
33. Otsuki T, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, Isozaki Y, Hyodoh F, Ueki H, Kusaka M, Kita S, Ueki A (2000) Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol 119:323-327
34. Ueki A, Isozaki Y, Tomokuni A, Hatayama T, Ueki H, Kusaka M (2002) Intermolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol 129:556-561
35. Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S, Otsuki T, Sakaguchi H, Hyodoh F (2005) Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunobiology 204:458-465
36. Ueki H, Kohda M, Nobutoh T, Yamaguchi M, Omori K, Miyashita Y, Hashimoto T, Komai A, Tomokuni A, Ueki A (2001) Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology 202:16-21
37. Nomura T, Sakaguchi S (2005) Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol 293:287-302